Duloxetine Delayed-Release Capsules
Reason CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.
2,661 recalls, newest first
Reason CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.
Reason CGMP Deviations
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Reason Failed dissolution specifications: lower than specifications
Reason LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations
Reason CGMP Deviations